Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic review
Biotech
US biotech finds Relief via reverse merger
Swiss biotech Relief Therapeutics is slated to enter a reverse merger with private U.S. biotech Renexxion and advance the latter’s GI pipeline.
Gabrielle Masson
Nov 4, 2024 1:05pm
MEI, after failed Infinity merger last year, faces its end
Jul 22, 2024 10:00am
Ikena cuts Hippo med, half of staff in latest reprioritization
May 29, 2024 9:15am
LianBio lays off half of workforce as biotech winds down
Feb 13, 2024 9:10am
Windtree's search for help shifts to full company sale
Jan 31, 2024 10:35am
2seventy splits again, sending cell therapy R&D to Regeneron
Jan 30, 2024 1:30pm
